by A clinical research coordinator runs a trial at the site level: consenting participants, keeping source documents accurate, entering data into the sponsor's EDC, and catching anything that drifts from the protocol or from ICH E6 GCP. Interviewers are checking whether you understand why those tasks matter, not just that you've done them before.
Expect at least one question about informed consent, one about adverse event or protocol deviation reporting, and a scenario that tests your judgment when something goes wrong mid-study. A site can lose its ability to enroll participants over a documentation problem, so a vague "I'm detail-oriented" answer won't get you far here.
These 20 questions cover what sites and CROs actually ask, with sample answers specific enough to show real GCP judgment.
Clinical research coordinator at a glance
| Item | Details |
|---|---|
| Typical employers | Academic medical centers, hospital health systems, physician-owned research sites, contract research organizations (CROs) |
| Median pay | $57,510 for biological technicians, the closest tracked occupation (BLS, May 2025); CRC-specific pay isn't broken out separately |
| Job outlook | 7% growth from 2025 to 2035 for biological technicians, about 9,400 openings a year (BLS) |
| Education | Bachelor's degree in a life science or nursing is typical; some sites hire with an associate degree plus clinical experience |
| Certification | Voluntary but increasingly preferred: CCRP (SOCRA) or CCRC (ACRP) |
| Key tools | EDC systems such as Medidata Rave, CTMS platforms, eTMF systems, IRB submission portals, CITI Program GCP training |
| Interview format | Interview with the principal investigator and/or a research manager, sometimes with a documentation or protocol scenario |
How the interview usually works
- Resume and credential screen. Sites look for prior GCP training (often through the CITI Program), study coordination or clinical experience, and familiarity with regulated documentation.
- Interview with the PI or research manager. Mixes background questions with technical ones on consent, source documentation, and adverse event reporting.
- A second conversation or site visit, common at academic medical centers, sometimes including a walkthrough of the regulatory binder or EDC.
- Reference checks and onboarding on the site's specific EDC, CTMS, and IRB, plus any GCP refresher training the site requires before you touch a live study.
General and background questions
1. What drew you to clinical research coordination, and what's your background in it?
Why they ask: They want a specific path into the role, not a general interest in medicine or science.
How to answer: Name the setting you came from and connect it to why coordination work fits you.
Sample answer: I worked as a clinical research assistant at an academic cancer center for 2 years, mostly on data entry and specimen tracking, and I coordinated my first study, a phase 2 breast cancer trial, once I finished CITI GCP training. What drew me to the coordinator role specifically is the mix of direct participant contact and the regulatory side. I like that a single day covers a consent visit, an EDC query from the sponsor, and prep for an upcoming monitoring visit.
2. Walk me through your experience with study startup, from IRB submission through first participant enrolled.
Why they ask: Startup involves several moving pieces, and they want to know you've actually managed the sequence, not just parts of it.
How to answer: Name the steps in order and where you personally owned the work.
Sample answer: For my last study, a phase 3 diabetes trial, I compiled the initial IRB submission packet, including the protocol, informed consent form, and investigator brochure, and tracked it through 2 rounds of IRB questions before approval. Once approved, I set up the regulatory binder, trained site staff on the protocol, and built our source document templates before we opened enrollment. From initial submission to first participant consented took about 11 weeks, which was faster than our site's average because I submitted IRB amendments in parallel with contract negotiation instead of waiting for both to finish sequentially.
3. What therapeutic areas or trial phases have you coordinated?
Why they ask: Phase and therapeutic area affect visit complexity, safety monitoring, and participant population, so they want your actual range.
How to answer: List specific areas and phases, and note any that are new to you.
Sample answer: I've coordinated 2 phase 2 oncology trials and 1 phase 3 cardiology device trial, with caseloads between 8 and 15 active participants at a time. The oncology studies had heavier adverse event tracking given the treatment toxicity profile, while the cardiology device trial had more procedural visits and imaging coordination. I haven't worked on a pediatric study yet, but I've read this site's open pediatric protocol and understand the added consent and assent requirements.
4. How do you stay current on ICH E6 GCP and FDA regulatory updates?
Why they ask: GCP guidance changes, and a coordinator who hasn't kept up can miss a documentation requirement without realizing it.
How to answer: Name specific resources and a recent update you've applied.
Sample answer: I follow FDA guidance documents directly rather than relying on secondhand summaries, and I read through the ICH E6(R3) principles and Annex 1 when FDA issued its final US guidance on the update in September 2025. I also do my required CITI Program refreshers on schedule rather than waiting until they lapse. After the E6(R3) update, I flagged to our research manager that our source document templates still referenced R2 language, and we updated them before our next monitoring visit.
Technical and role-specific questions
5. Walk me through how you obtain informed consent from a participant.
Why they ask: Consent is the most scrutinized part of a trial, and they want the actual sequence, not a summary.
How to answer: Describe the conversation, comprehension check, and documentation, in order.
Sample answer: I go through the consent form section by section rather than handing it over to read alone, since participants retain more when we talk through risks and alternatives together. I ask the participant to explain back to me in their own words what the study involves and what they can stop at any time, since that catches gaps a simple "any questions?" doesn't. Only after that do I have them sign and date, and I sign and date as the person obtaining consent, with a copy given to the participant the same day.
6. A participant seems confused about part of the consent form. What do you do?
Why they ask: Signing a confused participant is a GCP violation, and they want to see you'd stop the process rather than push through it.
How to answer: Describe pausing, clarifying, and escalating if needed.
Sample answer: I stop and go back to whatever section is unclear rather than continuing the visit, since a signature without real understanding isn't valid consent. Last month a participant in our diabetes trial didn't understand the difference between the study drug and their current medication continuing, so I drew out a simple timeline of their visit schedule and medications to walk through it again. If a participant still can't explain a key point back to me after that, I involve the PI directly rather than deciding on my own whether their understanding is good enough.
7. Describe your process for preparing an IRB continuing review or amendment.
Why they ask: Late or incomplete IRB submissions can put a site's ability to enroll on hold, so they want a real process.
How to answer: Describe your tracking system and lead time.
Sample answer: I track every study's IRB approval expiration date in a shared calendar with a 60-day alert, since most IRBs want continuing review materials at least 30 to 45 days before expiration. For an amendment, I compare the redlined protocol against our current consent form and source templates line by line to catch anything that needs updating beyond what the sponsor flagged. On one study, I caught that a dosing change in an amendment also required a change to our adverse event grading criteria, which the sponsor's summary hadn't mentioned.
8. What's your process for maintaining source documentation during a trial?
Why they ask: Source documents are what an auditor checks against the CRF, and sloppy source work is one of the most common audit findings.
How to answer: Describe your source document setup and correction process.
Sample answer: I build source templates for each visit before enrollment starts, mapped directly to the protocol's schedule of assessments, so nothing gets recorded from memory afterward. I document contemporaneously, during or immediately after the visit, not hours later from memory. When I need to correct an entry, I use a single line through the original, my initials, the date, and the reason, never an eraser or correction fluid, since that's a standard audit finding when it's done wrong.
9. Which EDC systems have you used, and how do you handle a data query from the sponsor?
Why they ask: EDC fluency varies a lot between coordinators, and query turnaround affects the sponsor's database lock timeline.
How to answer: Name specific systems and describe your query resolution process.
Sample answer: I've entered data in Medidata Rave on 2 studies and a smaller sponsor-built EDC on a third. When I get a query, I check the source document first before touching the CRF, since the fix should always trace back to source, not the other way around. If the discrepancy is a genuine source error rather than a data entry mistake, I correct the source first with a proper audit trail, then update the CRF and note the reason in the query response. I aim to close queries within 3 business days so they don't stack up before a monitoring visit.
10. Walk me through how you'd report a serious adverse event (SAE).
Why they ask: SAE reporting has strict timelines, and a mistake here has real safety and regulatory consequences.
How to answer: State the timeline and each party who gets notified.
Sample answer: Once I'm aware of a serious adverse event, I notify the PI immediately so they can assess causality and expectedness, and I report it to the sponsor within 24 hours per the protocol, using their SAE reporting form. I also submit an IRB report on whatever timeline that specific IRB requires, usually within 5 to 10 working days for a related, unexpected SAE. I keep a copy of every version of the SAE form and follow-up report in the regulatory file, since sponsors often ask for supplemental information as the event resolves.
11. What's the difference between an adverse event and a protocol deviation, and how do you document each?
Why they ask: Coordinators sometimes conflate the two, and they want confirmation you know they require separate documentation paths.
How to answer: Define both terms clearly and describe the separate logs.
Sample answer: An adverse event is any unfavorable medical occurrence in a participant, whether or not it's related to the study, and it gets logged on the AE case report form with severity and causality assessment. A protocol deviation is a departure from what the approved protocol specifies, like a visit happening outside its allowed window, and it goes in a separate deviation log with root cause and corrective action. The two can overlap, like a missed lab draw that also causes a safety concern, and when that happens I document both, cross-referencing the deviation log entry in the AE narrative so the two records agree.
12. How do you prepare for a monitoring visit or audit?
Why they ask: A rushed or disorganized visit signals wider documentation problems, and they want your standing preparation habits.
How to answer: Describe your ongoing organization, not just last-minute prep.
Sample answer: I try to keep the regulatory binder and source documents audit-ready between visits rather than scrambling before one, since a monitor's confidence in a site drops fast if things look thrown together. Before a scheduled visit, I pull every open query, pending signature, and outstanding IRB item into one list so I can walk the monitor through what's already in progress versus what's new. On my last visit, the monitor found one delegation log signature that was 4 days late, which I corrected and explained rather than disputed, since disputing a legitimate finding just extends the visit.
13. Do you hold a CCRP, CCRC, or another research certification?
Why they ask: Certification isn't required everywhere, but it signals a working knowledge of GCP and federal regulations beyond on-the-job training.
How to answer: State your certification status honestly, or your specific plan to pursue one.
Sample answer: I don't hold a certification yet. I have 2 years of full-time clinical research experience, which meets SOCRA's Category 1 eligibility for the CCRP exam, and I'm planning to apply this year. I've been studying the ICH guidelines and Code of Federal Regulations sections the exam covers using SOCRA's published exam outline. I'd rather be direct about where I am than overstate my credentials, since the exam itself would catch any gap in my knowledge anyway.
14. How do you manage the regulatory binder and essential documents for an active study?
Why they ask: An incomplete regulatory binder is one of the fastest ways to fail an audit, and they want a specific organizational system.
How to answer: Describe your filing structure and update cadence.
Sample answer: I organize the binder by ICH E6 essential document categories: protocol and amendments, IRB correspondence, delegation logs, training records, and informed consent versions, each in its own tab so nothing gets buried. I update the delegation log the same day any new staff member is added to a study rather than batching it monthly, since an untrained person entering data before they're on the log is a real finding. I also keep a version-controlled index at the front listing what's included, so a monitor or auditor can confirm completeness in minutes instead of flipping through everything.
Behavioral questions
15. Tell me about a time you caught a data entry error before it became a bigger problem.
Why they ask: They want to see attention to detail applied to something concrete, not a general claim of carefulness.
How to answer: Describe the error, how you caught it, and the fix.
Sample answer: While reconciling our paper source against the EDC before a monitoring visit, I noticed a participant's weight had been entered in pounds in one visit and kilograms in another, which would have thrown off a dosing calculation for a weight-based study drug. I flagged it to the PI immediately, corrected the source with a proper audit trail, and updated the CRF with a note explaining the discrepancy. We also added a unit reminder to the source template afterward so the same mistake couldn't happen with the next participant.
16. Tell me about a time a participant wanted to withdraw from a study.
Why they ask: Withdrawal has to be handled without pressure, and they want to see you respect a participant's right to leave.
How to answer: Describe how you responded and what you documented.
Sample answer: A participant in our oncology trial told me she wanted to withdraw after a difficult side effect, even though it wasn't a serious adverse event. I told her that was entirely her right and didn't try to talk her out of it, though I did ask if she'd be willing to complete an early termination visit for safety monitoring, which she agreed to. I documented her stated reason for withdrawal in her source notes and the EDC, and made sure the PI was aware so we could assess whether the side effect needed additional follow-up regardless of her withdrawal.
17. Tell me about a time you had to push back on a principal investigator.
Why they ask: Coordinators sometimes catch compliance issues the PI misses, and they want to know you'd raise it rather than defer automatically.
How to answer: Describe the disagreement and how you resolved it professionally.
Sample answer: A PI wanted to enroll a participant who was borderline on one inclusion criterion, arguing the intent of the criterion was met even if the exact lab value wasn't. I pushed back and said we needed a documented protocol deviation or a sponsor waiver rather than enrolling and hoping it wouldn't come up at monitoring, since enrolling an ineligible participant without documentation is a serious finding. We called the sponsor's medical monitor together, got a written waiver before enrollment, and the PI later told me he appreciated that I'd stopped him from creating an undocumented problem.
Situational questions
18. A participant misses a required visit window. What do you do?
Why they ask: Missed windows are common, and they want your triage process, not just an acknowledgment that it happens.
How to answer: Describe assessing the impact, documenting it, and adjusting the plan.
Sample answer: I'd first check whether the protocol allows any flexibility in that visit's window and whether missing it affects a primary endpoint measurement or just a secondary one. I'd document it as a protocol deviation with the specific reason, like a participant's transportation issue, and note whether any assessment can still be captured late versus not at all. I'd also talk to the participant about what caused the miss, since a pattern, like recurring transportation problems, might mean we need to adjust their visit schedule going forward rather than just logging repeated deviations.
19. You discover a protocol deviation from 3 weeks ago that was never reported. What's your process now?
Why they ask: Late discovery happens, and they want to see you report it rather than quietly correct it and move on.
How to answer: Describe immediate reporting and root cause review.
Sample answer: I'd report it the same day I find it, not wait to gather more context first, since the timeline itself is often part of what the IRB and sponsor need to know. I'd document what happened, when it happened, and when I discovered it, being honest about the 3-week gap rather than softening it. Then I'd look at why it wasn't caught sooner, whether that's a gap in our review process, and bring a specific fix to the research manager, like a weekly deviation review instead of relying on catching things as they come up.
20. An auditor finds a discrepancy between your source document and the CRF. Walk me through your response.
Why they ask: How you respond to a finding, defensively or constructively, tells them a lot about how you'll handle real audits.
How to answer: Describe reviewing the discrepancy honestly and correcting it with proper documentation.
Sample answer: I'd pull both documents and figure out which one is actually wrong before saying anything defensive, since sometimes the source is right and the CRF wasn't updated, and sometimes it's the other way around. If the CRF is wrong, I'd correct it with a proper audit trail and query response explaining the discrepancy. I wouldn't argue with the auditor's finding if it's accurate, since disputing a correct finding just costs credibility; I'd rather acknowledge it, fix it properly, and explain what I'm doing to prevent the same gap on the next participant.
Questions to ask the interviewer
- What EDC and CTMS does the site use, and what does training on them look like for a new coordinator?
- What's the current caseload per coordinator, and how many active studies would I be supporting?
- Who provides backup coverage for visits and monitoring calls when a coordinator is out?
- Does the site work with a central IRB, a local IRB, or both?
- What's a recent monitoring visit finding the site has worked to fix?
- Is there support for CCRP or CCRC exam fees or study time?
How to prepare
- Know the ICH E6(R3) principles well enough to talk through them without notes, since GCP knowledge comes up in nearly every coordinator interview.
- Be ready to define an adverse event, a serious adverse event, and a protocol deviation precisely, and describe how each gets documented.
- Review the informed consent process in detail, including what changes when a participant's capacity to consent is in question.
- Prepare 2 or 3 specific stories: a data error you caught, a difficult participant conversation, and a monitoring visit or audit finding you resolved.
- Know the EDC and source documentation systems on your resume well enough to describe an actual query or correction you handled.
If you're comparing this role to other clinical support positions, our clinical pharmacist interview questions guide covers a related medication-focused role, and our RN case manager interview questions guide covers a similar documentation-heavy nursing role. For a related lab-facing role, see our phlebotomist interview questions guide, and if you're building materials for this specific search, our clinical research coordinator cover letter guide is next.